Authors
Roland Haubner, Hans-Jürgen Wester, Fred Burkhart, Reingard Senekowitsch-Schmidtke, Wolfgang Weber, Simon L Goodman, Horst Kessler, Markus Schwaiger
Publication date
2001/2/1
Journal
Journal of Nuclear Medicine
Volume
42
Issue
2
Pages
326-336
Publisher
Society of Nuclear Medicine
Description
The αVβ3 integrin plays an important role in metastasis and tumor-induced angiogenesis. Targeting with radiolabeled ligands of the αVβ3 integrin may provide information about the receptor status and enable specific therapeutic planning. Previous studies from our group resulted in tracers that showed αVβ3-selective tumor uptake. However, these first-generation compounds predominantly revealed hepatobiliary excretion with high radioactivity found in the liver. In this report, the synthesis and biological evaluation of the first glycosylated RGD-containing peptide (RGD-peptide) for the noninvasive imaging of αVβ3 expression are described.
Methods
Peptides were assembled on a solid support using fluorenylmethoxycarbonyl-coupling protocols. The precursor cyclo(-Arg-Gly-Asp-d-Tyr-Lys(SAA)-) GP1 was synthesized by coupling 3-acetamido-2,6-anhydro-4,5,7-tri-O-benzyl-3-deoxy-β-d-glycero-d-gulo-heptonic …
Total citations
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024626294042433747374029343221241810191181925123